Bolt Biotherapeutics (BOLT) stock news · rev $7.7M
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
This BOLT news page leads with what Bolt Biotherapeutics filed — not a scraped headline mill.
No cached 8-K sentence for BOLT yet. We will not pad this page with generic market recap.
Latest reported BOLT revenue for 2025-12-31 was $7.7M. Net income was -$33.4M. Revenue was up 0.1% from 2024-12-31 to 2025-12-31. BOLT currently screens at market cap $11.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BOLT stock page; for the tape open the quote page.
BOLT stock news FAQ
What are BOLT's latest revenue and net income?
Latest cached Bolt Biotherapeutics (BOLT) revenue for Dec 31, 2025 was $7.7M. Net income was -$33.4M. Statements: https://lician.com/financials/bolt
How did BOLT revenue change from the prior cached period?
Cached Bolt Biotherapeutics (BOLT) revenue was up 0.1% from $7.7M (Dec 31, 2024) to $7.7M (Dec 31, 2025). Statements: https://lician.com/financials/bolt
What is BOLT's market cap?
Bolt Biotherapeutics (BOLT) market cap is $11.3M on the latest cached fundamentals snapshot.
What kind of company is BOLT?
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Where is BOLT stock news listed?
Cached stock news for Bolt Biotherapeutics (BOLT) is listed at https://lician.com/news/bolt. Filings: https://lician.com/sec/bolt
Not investment advice.